5.6 C
Glasgow
Monday, March 16, 2026
spot_img
Homebiotech

biotech

Stay Connected
- Advertisement -spot_img
Latest Articles

Severe atopic dermatitis drug sees positive study results

Pfizer Inc. has announced positive topline results from a phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate to severe atopic dermatitis. The study...